ROLE OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN ELDERLY HYPERTENSIVES WITH COMORBIDITY: FROM CLINICAL TRIALS TO REAL WORLD

被引：0
|
作者：
Mazza, Alberto [1 ]
Torin, Gioia [2 ]
Schiavon, Laura [2 ]
Rossetti, Ciro [2 ]
Cuppini, Stefano [2 ]
机构：
[1] Rovigo Gen Hosp, AULSS5 Polesana, ESH Excellence Hypertens Ctr, Rovigo, Italy
[2] Rovigo Gen Hosp, AULSS5 Polesana, Internal Med Unit, Rovigo, Italy
来源：
JOURNAL OF HYPERTENSION | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E279 / E279
页数：1
相关论文
共 50 条
  • [1] The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings
    Mazza, Alberto
    Townsend, Danyelle M.
    Torin, Gioia
    Schiavon, Laura
    Camerotto, Alessandro
    Rigatelli, Gianluca
    Cuppini, Stefano
    Minuz, Pietro
    Rubello, Domenico
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [2] Sacubitril/Valsartan in heart failure with reduced ejection fraction: clinical and echocardiographic insights from a real world population
    Valli, F.
    Bursi, F.
    Santangelo, G.
    Toriello, F.
    Rusconi, I.
    Mondellini, G.
    Vella, A. M.
    Faggiano, A.
    Persampieri, S.
    Carugo, S.
    Guazzi, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 785 - 785
  • [3] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [4] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
  • [5] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [6] Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience
    Ferreira, F. A. C.
    Cristina, S.
    Raposo, A. F.
    Albuquerque, E. M.
    Nabais, I.
    Matias, C. S.
    Nogueira, M. A.
    Vasconcellos, R. C. A.
    Proenca, G. M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 229
  • [7] THE COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A618
  • [8] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
    Nordberg Backelin, Charlotte
    Fu, Michael
    Ljungman, Charlotta
    ESC HEART FAILURE, 2020, 7 (03): : 1049 - 1055
  • [9] Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real-world study
    Wang, Chen
    Lin, Zongwei
    Miao, Dongxia
    Zhang, Hui
    Fu, Kang
    Zhang, Xinyu
    Xiao, Jie
    Hu, Yue
    Sun, Yijun
    Wang, Fen
    Lu, Huixia
    Ji, Xiaoping
    ESC HEART FAILURE, 2023, 10 (03): : 1961 - 1971
  • [10] Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction
    Mapelli, Massimo
    Salvioni, Elisabetta
    de Martino, Fabiana
    Mattavelli, Irene
    Bonomi, Alice
    Sassi, Valentina
    Gugliandolo, Paola
    Vignati, Carlo
    Magini, Alessandra
    Rovai, Sara
    Paolillo, Stefania
    Agostoni, Piergiuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (11) : 882 - 888
12345